Heinz Reichmann, EAN 2020 – OPTIPARK Study in Patients with Parkinson’s and Motor Fluctuations
Heinz Reichmann (Universitätsklinikum Carl Gustav Carus, Dresden, Germany) shares key findings and expert insights into the OPTIPARK study, a prospective, open-label, uncontrolled, single-group, multi-centre trial in patients with Parkinson’s disease and wearing-off motor fluctuations (ClinicalTrials.gov Identifier: NCT02847442). Questions 1. What were the aims and design of the OPTIPARK study? (0:05) 2. What were the efficacy […]